Atlas Trials

Evaluation of Dosing Interval of Higher Doses of Ranibizumab

Clinical trial NCT00533520 · COMPLETED

Trial details

NCT number
NCT00533520
Sponsor
Brandon G. Busbee, MD
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Macular DegenerationChoroidal Neovascularization
Start date
2007-09-01
Primary completion
2013-11-01
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.